An appeals court has upheld a 2017 decision recognizing scientists from the Broad Institute of Harvard and MIT as the true inventors of the CRISPR-Cas9 gene-editing system. The decision likely signifies the end of a bitter legal dispute that began four years ago.
Science’s next space race isn’t in the stars, but in your DNA. People around the world are working to use the latest DNA-editing technology, called CRISPR-Cas9, to fix the gene-based ails that plague so many victims. But this is still science—which means every side faces scrutiny, even from the folks supposed to be on…
The Planet of the Apes prequels did much to explain how humans lost their status as the dominant species on the planet—a cataclysmic set of events fueled by a global pandemic known as the “Simian Flu.” This virus, the product of a medical experiment gone horribly wrong, wiped out the vast majority of humans, but it…
A team of scientists in China has become the first to treat a human patient with the groundbreaking CRISPR-Cas9 gene-editing technique. While the results of the trial are uncertain, it’s a historic milestone that should serve as a serious wakeup call to the rest of the world.
Agriculture company Monsanto has acquired a non-exclusive global licensing agreement from MIT’s Broad Institute and Harvard to use the CRISPR/Cas9 gene-editing system. The firm will use it to design and grow new seeds and plants, but there are key restrictions on its use to prevent Monsanto from abusing this…
Leveraging the pre-existing power of CRISPR, a team of researchers has made an important adjustment to the groundbreaking gene-editing tool that could make it precise enough for human applications.
A mushroom that’s resistant to browning has become the first CRISPR-edited food to get green lit by the US government. Here’s how this mutated fungus managed to escape USDA oversight—and why this agency needs to upgrade its regulatory guidelines.
Just one year after scientists in China made history by modifying the DNA of human embryos, a second team of Chinese researchers has done it again. Using CRISPR/Cas9, the researchers introduced HIV-resistance into the embryos, showcasing the tremendous potential for gene-editing.
Researchers from Temple University have used the CRISPR/Cas9 gene editing tool to clear out the entire HIV-1 genome from a patient’s infected immune cells. It’s a remarkable achievement that could have profound implications for the treatment of AIDS and other retroviruses.
A group of geneticists has called for a moratorium on research into modifying heritable human DNA — a practice that could lead to so-called "designer babies." But as scientists consider this drastic proposal, they should also recognize the potential benefits this technology could afford – and the risks of an outright…
![The Final <i>Fantastic Beasts </i>Sequel Trailer Teases a Surprising Character Reveal [Updated]](https://i.kinja-img.com/gawker-media/image/upload/s--WTZMrAnR--/c_fill,f_auto,fl_progressive,g_center,h_180,q_80,w_320/gtqx9kjtqkahumsgj1pg.png)
